Effect of Applicator Reconstruction Shifting on Dosimetric Dose-Volume Histogram Parameters during Magnetic Resonance Imaging in Brachytherapy for Cervical Cancer Patients
Objective: This study observed the dose-volume histogram (DVH) parameter changes caused by applicator shifting that result from patient movement during image acquisition for magnetic resonance imaging guided brachytherapy for cervical cancer patients.
Materials and Methods: Nine cervical cancer plans with insertion of a Fletcher computed tomography (CT)/magnetic resonance (MR) applicator were retrospectively studied. The MR sequences were T2 fast spin echo on parasagittal, para-axial, and para-coronal planes, respectively. The applicator library was used for applicator reconstruction in each image data set. The tip of the applicator (2 ovoids + 1 tandem) was identified, and the difference from the reference image (axial view) was recorded. The DVH parameters were as follows: D90 of high-risk clinical target volume (HR-CTV) and D2cc of the bladder and rectum for each image data set were compared with the reference image.
Results: The tandem showed less applicator shift on the coronal plane than the reference image. The applicator shifts for tandem were 0.0 ± 0.4, 0.0 ± 1.0, and -0.5 ± 1.0 mm in the left-right, superior-inferior, and anterior-posterior directions, respectively. The mean percentage dose differences in DVH parameters on the coronal and sagittal planes were 3.04% and 1.23% for D90 of HR-CTV, 2.73% and 3.88% for D2cc of the bladder, and 2.60% and 3.49% for D2cc of the rectum, respectively.
Conclusion: An image acquisition time of approximately 15 minutes for three-dimensional MR brachytherapy provided a mean applicator reconstruction shift within 1.3 mm, with minor effects on the DVH parameter of approximately 3%.
- Source: annual survey 2013-2014. http://www.thastro.org/index.php/2014-03-27-01-07-52. Date accessed: 01/02/2016.
- ICRU Report 38. Dose and volume specification for reporting intracavitary therapy in gynecology. International Commission on Radiation Units and Measurement. Bethesda, Maryland, 1985.
- R. Potter, E.V. Limbergen, N. Gerstner, A. Wambersie. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiotherapy and Oncology. 2001; 58(1), 11-18.
- J. Dimopoulos, P. Petrow, K. Tanderup, P. Petric, D. Berger, C. Kirisits . Recommendations from gynecological (GYN) GEC-ESTRO working group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiotherapy and Oncology. 2012; 103(1), 113-122.
- T.P. Hellebust, C. Kirisits, D. Berger, Perez-Calatayud, M. Brabandere, A.A. Leeuw. Recommendations from gynaecological (GYN) GEC-ESTRO working group: Considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiotherapy and Oncology. 2010; 96(2), 153-160.
- E.M. Kerkhof, R.W. van der Put, B.W. Raaymakers, U.A. van der Heide, I.M. Jurgenliemk-Schulz, J.J.W. Lagendijk. Intrafraction of the primary CTV in patients with cervical cancer: an assessment by repeated MR imaging. Radiotherapy and Oncology. 2008; 88, S108.
- J. Schindel, W. Zhang, S.K. Bhatia, W. Sun, Y. Kim. Dosimetric impacts of applicator displacements and applicator reconstruction-uncertainties on 3D image-guided brachytherapy for cervical cancer. Journal of Contemporary Brachytherapy. 2013; 5(4), 250-257.
- K. Tanderup, T.P. Hellebust, S. Lang, J. Granfeldt, R. Potter, J.C. Lindegaard. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. Radiotherapy and Oncology. 2008; 89, 156-163.
- K. Tenderup, N. Nesvacil, R. Potter, C. Kirisits. Uncertainty in image guided adaptive cervix cancer brachytherapy: Impact on planning and prescription. Radiotherapy and Oncology. 2013; 107, 1-5.
- A.A.C. De Leeuw, M.A. Moerland, C. Nomden, R.H.A. Tersteeg, J.M. Roesink, I.M. Jurgenliemk-Schulz. Applicator reconstruction and applicator shifts in 3D-MR-based PDR brachytherapy of cervical cancer. Radiotherapy and Oncology. 2009; 93(2), 341-346.
- There are currently no refbacks.